Post Covid 19 Epidemic Era Artificial Blood Substitutes Industry

Post-Covid-19 Epidemic Era, Artificial Blood Substitutes Industry Development Trend Analysis Report 2023

Post Covid 19 Epidemic Era Artificial Blood Substitutes Industry

Post-Covid-19 Epidemic Era, Artificial Blood Substitutes Industry Development Trend Analysis Report 2023


The Global Artificial Blood Substitutes Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like {playerNamesStr}

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Artificial Blood Substitutes market size in 2022 is XX million US dollars, and it is expected to be 24080.0 million US dollars by 2029, with a compound annual growth rate of 20.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Artificial Blood Substitutes market include Aurum Biosciences (U.K.), HEMARINA (France), Hemoglobin Oxygen Therapeutics LLC (U.S.), KaloCyte Inc. (U.S.), and SpheriTech Ltd. (U.K.). The share of the top 3 players in the Artificial Blood Substitutes market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Artificial Blood Substitutes market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Perflurocarbon (PFCs) accounted for XX% of Artificial Blood Substitutes market in 2022. Hemoglobin-Based Oxygen Carries (HBOCs) share of XX%.

Cardiovascular Diseases accounted for XX% of the Artificial Blood Substitutes market in 2022. Malignant Neoplasma accounts for XX%.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Artificial Blood Substitutes Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.

Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.

 

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America

United States

Canada

China

Asia Pacific (Excluding China)

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Nordic

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

Player list

Aurum Biosciences (U.K.)

HEMARINA (France)

Hemoglobin Oxygen Therapeutics LLC (U.S.)

KaloCyte Inc. (U.S.)

SpheriTech Ltd. (U.K.)

Centrum Medyczne VisusMed (Poland)

European Medicines Agency (Netherlands)

OPK Biotech Inc. (U.S.)

NuvOx Pharma (U.S.)

Prolong Pharmaceuticals, LLC

Boston Pharmaceuticals (U.S.)

OXYVITA Inc (U.S.)

NanoBlood LLC (U.S.)

Types list

Perflurocarbon (PFCs)

Hemoglobin-Based Oxygen Carries (HBOCs)

Oxyglobin

Hemopure

Application list

Cardiovascular Diseases

Malignant Neoplasma

Injuries

Neonatal Conditions

Organ Transplant and Maternal Condition

Table of Content

1 Artificial Blood Substitutes Market Introduction and Overview

1.1 Artificial Blood Substitutes Definition

1.2 Market Size Analysis by Types

1.3 Market Size Analysis by Application

1.4 Research Purposes

1.5 Report Timeline

1.6 Economic Analysis of Global Regions

2 Players Profiles

2.1 Aurum Biosciences (U.K.)

2.1.1 Aurum Biosciences (U.K.) Company Profile

2.1.2 Artificial Blood Substitutes Product Overview

2.1.3 Aurum Biosciences (U.K.) Artificial Blood Substitutes Market Performance (2018-2023)

2.1.4 Aurum Biosciences (U.K.) Business Overview

2.2 HEMARINA (France)

2.2.1 HEMARINA (France) Company Profile

2.2.2 Artificial Blood Substitutes Product Overview

2.2.3 HEMARINA (France) Artificial Blood Substitutes Market Performance (2018-2023)

2.2.4 HEMARINA (France) Business Overview

2.3 Hemoglobin Oxygen Therapeutics LLC (U.S.)

2.3.1 Hemoglobin Oxygen Therapeutics LLC (U.S.) Company Profile

2.3.2 Artificial Blood Substitutes Product Overview

2.3.3 Hemoglobin Oxygen Therapeutics LLC (U.S.) Artificial Blood Substitutes Market Performance (2018-2023)

2.3.4 Hemoglobin Oxygen Therapeutics LLC (U.S.) Business Overview

2.4 KaloCyte Inc. (U.S.)

2.4.1 KaloCyte Inc. (U.S.) Company Profile

2.4.2 Artificial Blood Substitutes Product Overview

2.4.3 KaloCyte Inc. (U.S.) Artificial Blood Substitutes Market Performance (2018-2023)

2.4.4 KaloCyte Inc. (U.S.) Business Overview

2.5 SpheriTech Ltd. (U.K.)

2.5.1 SpheriTech Ltd. (U.K.) Company Profile

2.5.2 Artificial Blood Substitutes Product Overview

2.5.3 SpheriTech Ltd. (U.K.) Artificial Blood Substitutes Market Performance (2018-2023)

2.5.4 SpheriTech Ltd. (U.K.) Business Overview

2.6 Centrum Medyczne VisusMed (Poland)

2.6.1 Centrum Medyczne VisusMed (Poland) Company Profile

2.6.2 Artificial Blood Substitutes Product Overview

2.6.3 Centrum Medyczne VisusMed (Poland) Artificial Blood Substitutes Market Performance (2018-2023)

2.6.4 Centrum Medyczne VisusMed (Poland) Business Overview

2.7 European Medicines Agency (Netherlands)

2.7.1 European Medicines Agency (Netherlands) Company Profile

2.7.2 Artificial Blood Substitutes Product Overview

2.7.3 European Medicines Agency (Netherlands) Artificial Blood Substitutes Market Performance (2018-2023)

2.7.4 European Medicines Agency (Netherlands) Business Overview

2.8 OPK Biotech Inc. (U.S.)

2.8.1 OPK Biotech Inc. (U.S.) Company Profile

2.8.2 Artificial Blood Substitutes Product Overview

2.8.3 OPK Biotech Inc. (U.S.) Artificial Blood Substitutes Market Performance (2018-2023)

2.8.4 OPK Biotech Inc. (U.S.) Business Overview

2.9 NuvOx Pharma (U.S.)

2.9.1 NuvOx Pharma (U.S.) Company Profile

2.9.2 Artificial Blood Substitutes Product Overview

2.9.3 NuvOx Pharma (U.S.) Artificial Blood Substitutes Market Performance (2018-2023)

2.9.4 NuvOx Pharma (U.S.) Business Overview

2.10 Prolong Pharmaceuticals, LLC

2.10.1 Prolong Pharmaceuticals, LLC Company Profile

2.10.2 Artificial Blood Substitutes Product Overview

2.10.3 Prolong Pharmaceuticals, LLC Artificial Blood Substitutes Market Performance (2018-2023)

2.10.4 Prolong Pharmaceuticals, LLC Business Overview

2.11 Boston Pharmaceuticals (U.S.)

2.11.1 Boston Pharmaceuticals (U.S.) Company Profile

2.11.2 Artificial Blood Substitutes Product Overview

2.11.3 Boston Pharmaceuticals (U.S.) Artificial Blood Substitutes Market Performance (2018-2023)

2.11.4 Boston Pharmaceuticals (U.S.) Business Overview

2.12 OXYVITA Inc (U.S.)

2.12.1 OXYVITA Inc (U.S.) Company Profile

2.12.2 Artificial Blood Substitutes Product Overview

2.12.3 OXYVITA Inc (U.S.) Artificial Blood Substitutes Market Performance (2018-2023)

2.12.4 OXYVITA Inc (U.S.) Business Overview

2.13 NanoBlood LLC (U.S.)

2.13.1 NanoBlood LLC (U.S.) Company Profile

2.13.2 Artificial Blood Substitutes Product Overview

2.13.3 NanoBlood LLC (U.S.) Artificial Blood Substitutes Market Performance (2018-2023)

2.13.4 NanoBlood LLC (U.S.) Business Overview

3 Global Artificial Blood Substitutes Historical and Forecast Market Analysis by Type

3.1 Global Artificial Blood Substitutes Revenue and Market Share by Type

3.2 Global Artificial Blood Substitutes Revenue Market Forecast by Type (2023-2029)

4 Global Artificial Blood Substitutes Historical and Forecast Market Analysis by Application

4.1 Global Artificial Blood Substitutes Revenue Market Share by Application (2018-2023)

4.2 Artificial Blood Substitutes Revenue Market Forecast by Application (2023-2029)

5 Global Market Growth Trends Analysis

5.1 Global Artificial Blood Substitutes Market Size & Forecast (2018-2029)

5.2 Artificial Blood Substitutes Growth Trends Analysis by Regions

5.2.1 Artificial Blood Substitutes Market Size by Regions: 2018 VS 2023 VS 2029

5.2.2 Artificial Blood Substitutes Historic Market Size by Regions (2018-2023)

5.2.3 Artificial Blood Substitutes Forecasted Market Size by Regions (2023-2029)

5.2.4 North America Artificial Blood Substitutes Market Size & Forecast (2018-2029)

5.2.5 Europe Artificial Blood Substitutes Market Size & Forecast (2018-2029)

5.2.6 China Artificial Blood Substitutes Market Size & Forecast (2018-2029)

5.2.7 Asia-Pacific (Excluding China) Artificial Blood Substitutes Market Size & Forecast (2018-2029)

5.2.8 Latin America Artificial Blood Substitutes Market Size & Forecast (2018-2029)

5.2.9 Middle East & Africa Artificial Blood Substitutes Market Size & Forecast (2018-2029)

6 North America

6.1 North America Artificial Blood Substitutes Revenue by Players

6.2 North America Artificial Blood Substitutes Revenue by Types

6.3 North America Artificial Blood Substitutes Revenue by Applications

6.4 North America Artificial Blood Substitutes Market by Countries

6.4.1 North America Artificial Blood Substitutes Revenue by Countries (2018-2029)

6.5 United States

6.6 Canada

7 China

7.1 China Artificial Blood Substitutes Revenue by Players

7.2 China Artificial Blood Substitutes Revenue by Types

7.3 China Artificial Blood Substitutes Revenue by Applications

7.4 China

8 Asia Pacific (Excluding China)

8.1 Asia Pacific Artificial Blood Substitutes Revenue by Players

8.2 Asia Pacific Artificial Blood Substitutes Revenue by Types

8.3 Asia Pacific Artificial Blood Substitutes Revenue by Applications

8.4 Asia Pacific Artificial Blood Substitutes Market by Countries

8.4.1 Asia Pacific Artificial Blood Substitutes Revenue by Countries (2018-2029)

8.5 Japan

8.6 Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Europe

9.1 Europe Artificial Blood Substitutes Revenue by Players

9.2 Europe Artificial Blood Substitutes Revenue by Types

9.3 Europe Artificial Blood Substitutes Revenue by Applications

9.4 Europe Artificial Blood Substitutes Market by Countries

9.4.1 Europe Artificial Blood Substitutes Revenue by Countries (2018-2029)

9.5 Germany

9.6 France

9.7 UK

9.8 Italy

9.9 Russia

9.10 Nordic

10 Latin America

10.1 Latin America Artificial Blood Substitutes Revenue by Players

10.2 Latin America Artificial Blood Substitutes Revenue by Types

10.3 Latin America Artificial Blood Substitutes Revenue by Applications

10.4 Latin America Artificial Blood Substitutes Market by Countries

10.4.1 Latin America Artificial Blood Substitutes Revenue by Countries (2018-2029)

10.5 Brazil

10.6 Argentina

10.7 Mexico

11 Middle East & Africa

11.1 Middle East & Africa Artificial Blood Substitutes Revenue by Players

11.2 Middle East & Africa Artificial Blood Substitutes Revenue by Types

11.3 Middle East & Africa Artificial Blood Substitutes Revenue by Applications

11.4 Middle East & Africa Artificial Blood Substitutes Market by Countries

11.4.1 Middle East & Africa Artificial Blood Substitutes Revenue by Countries (2018-2029)

11.5 Egypt

11.6 South Africa

11.7 Israel

11.8 Turkey

11.9 GCC Countries

12 Artificial Blood Substitutes Industry Dynamic Analysis

12.1 Artificial Blood Substitutes Market Trends Analysis

12.2 Artificial Blood Substitutes Market Drivers Analysis

12.3 Artificial Blood Substitutes Market Challenges Analysis

12.4 Artificial Blood Substitutes Market Restraints Analysis

12.5 Artificial Blood Substitutes Industry Mergers & Acquisitions

12.6 Artificial Blood Substitutes Industry New Entrants and Expansion Plans

13 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Artificial Blood Substitutes Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Artificial Blood Substitutes Market?
New players are entering the Artificial Blood Substitutes Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What are the major applications for Artificial Blood Substitutes?
Artificial Blood Substitutes has a wide range of applications, including and others.
What is the estimated size & growth rate of the Artificial Blood Substitutes Market?
In recent years, the Artificial Blood Substitutes Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What is really changing the Artificial Blood Substitutes Market behavior?
Consumer behavior changes will reshape the entire decision-making process and companies in the Artificial Blood Substitutes Industry will need to adapt quickly.
How is the Artificial Blood Substitutes Market's changing dynamics captured?
The Artificial Blood Substitutes analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.